DOW JONES22,234.96+1182.43 5.62%
S&P 5002,627.23+138.58 5.57%
NASDAQ7,785.03+411.94 5.59%

Oppenheimer Maintains Outperform on DexCom, Raises Price Target to $305

Oppenheimer maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $285 to $305.

Benzinga · 03/06/2020 16:39

Oppenheimer maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $285 to $305.